This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Industry news
Industry news
UCB launches an offer of up to €350 million convertible bonds
Abbott buys Solvay drugs empire
Professor receives Fulbright award
Boehringer Ingelheim Animal Health enters into agreement
Global vaccine-research partnership
J&J reduces Elan partnership deal
Arpida and Evolva plan merger
Shire announces FDA approval of Intuniv
Pfizer fined record $2.3 billion
FDA refuses leukaemia-drug approval
Post-Shipman rules “working well”
J&J cutting four business groups
« Previous
1
…
17
18
19
20
21
…
45
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: